Functional Human Brown Adipocyte Differentiation via PPARγ and Beta-Adrenergic Stimulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating functional human brown adipocytes are inadequate, as existing human brown adipocyte models lack the necessary uncoupling activity and respiratory function, and the conversion of white to brown adipocytes is not effectively stimulated by β-adrenergic receptor agonists.

Innovation Solution

A method for differentiating human multipotent adipose-derived stem cells (hMADS cells) into a functional brown adipocyte population by prolonged chronic activation of PPARγ and stimulation with β-adrenergic receptor agonists, resulting in increased expression of UCP1, CIDEA, CPT1B, and Bcl-2, and reduced expression of Bax, with similar expression levels of PPARα, PGC-1α, PGC-1β, and PRDM16 compared to white adipocytes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to generate human brown adipocytes, then cell production is achieved, but uncoupling activity and respiratory function are insufficient

Engineering Contradiction:
Improveuncoupling activityVSAvoidcell production method
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes the differentiation parameters by using prolonged chronic PPARγ activation combined with β-adrenergic receptor agonist stimulation. This dual-parameter approach transforms the differentiation protocol to achieve functional brown adipocytes with proper uncoupling activity and respiratory function, resolving the contradiction between reliable cell production and functional performance.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies preliminary action by first establishing white adipocyte differentiation through PPARγ activation, then sequentially introducing β-adrenergic stimulation to convert them to brown adipocytes. This stepwise preliminary differentiation ensures cells are properly primed before functional conversion, achieving both manufacturability and functional reliability.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If white adipocytes are converted to brown adipocytes without proper stimulation, then conversion is achieved, but respiratory activity is not sufficiently stimulated

Engineering Contradiction:
Improveconversion efficiencyVSAvoidrespiratory activity
Core Design Contradiction:
ProductivityVSPower

Solution Approach 1:

The patent implements continuity of useful action by maintaining prolonged chronic PPARγ activation throughout the differentiation and conversion process, combined with continuous β-adrenergic receptor agonist stimulation. This continuous dual-stimulation approach ensures both efficient conversion and sustained high respiratory activity, resolving the contradiction between conversion efficiency and functional power.

Inventive Principle:
Principle #20Continuity of useful action

3Adaptability or versatility

If β-adrenergic receptor agonists are used to stimulate conversion, then conversion is enhanced, but uncoupling protein expression is not sufficiently increased

Engineering Contradiction:
Improveconversion responsivenessVSAvoidUCP1 expression
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent merges two stimulation approaches by combining PPARγ agonist treatment with β-adrenergic receptor agonist stimulation. This combination therapy synergistically enhances both the conversion responsiveness and the UCP1 expression levels, resolving the contradiction between adaptability to stimulation and quantity of uncoupling protein produced.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting functional human brown adipocytes exhibit significantly higher respiratory and uncoupling activities, which can be further stimulated by β-adrenergic receptor agonists, providing a viable model for modulating body weight and treating obesity.

Implementation Method 1

the present invention relates to a functional human brown adipocytes population which simultaneously expresses the following genes... obtained by differentiating a population of human multipotent adipose-derived stem cells (hMADS cells) by stimulation with PPARγ receptor agonistic ligands

Methodology Applied
Scientific EffectNuclear receptor activation:

Implementation Method 2

the respiratory activity of which can be stimulated by a specific agonist of β-adrenergic receptors... the expression of which is increased after stimulation by a specific agonist of β-adrenergic receptors

Methodology Applied
Scientific EffectG-protein coupled receptor activation:

Implementation Method 3

brown adipose tissue (BAT) is specialized in adaptive thermogenesis during which the uncoupling protein UCP1 plays a decisive role... the uncoupling activity of which is significantly higher compared with the respiratory activity and the uncoupling activity of any other cell type

Methodology Applied
Scientific EffectUncoupling protein-mediated oxidative phosphorylation uncoupling:

Data Source

PatentUS9790469B2Established human brown adipocyte line and method for differentiation from an hMADS cell line
Publication Date: 2017.10.17 CENT NAT DE LA RECH SCI (C N R S)
  • US9790469B2 patent drawing
  • US9790469B2 patent drawing
  • US9790469B2 patent drawing

AI summary

The subject matter of the invention is a functional population of human brown adipocytes, in which the expression of UCP1, CIDEA, CPT1B and Bc12 is higher, the expression of Bax is lower and the expression of PPAR-alpha, PGC-1alpha, PGC-1 beta and PRDM16 is similar compared with the corresponding expressions of a population of human white adipocytes. The invention also relates to a method for differentiation of hMADS cells into the functional population of human brown adipocytes, to a method for conversion of a population of human white adipocytes into the functional population of human brown adipocytes, and also to a method of screening for molecules capable of modulating the bodyweight in an individual.